These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3095392)
41. Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside. Teicher BA; Holden SA; Northey D; Dewhirst MW; Herman TS Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):103-9. PubMed ID: 8482616 [TBL] [Abstract][Full Text] [Related]
42. Detection of early myocardial tissue changes in acute canine myocardial infarction by ultrasonic tissue characterization methods. Tak T; Gamage N; Lin SL; Mahler C; Steen SN; Coletti P; Rahimtoola SH; Chandraratna PA Can J Cardiol; 1989; 5(8):408-12. PubMed ID: 2605550 [TBL] [Abstract][Full Text] [Related]
43. Cold protected hearts extract oxygen from Fluosol-DA during cardiopulmonary bypass. Gartman DM; McDonagh PF; Geha AS Adv Exp Med Biol; 1984; 180():443-50. PubMed ID: 6534118 [No Abstract] [Full Text] [Related]
44. Hemodilution and myocardial oxygen supply. The influence of fluosol-DA. Vogel H; Günther H; Harrison DK; Anderer W; Kessler M; Peter K Adv Exp Med Biol; 1989; 248():653-61. PubMed ID: 2782181 [No Abstract] [Full Text] [Related]
45. Verification of myocardial contrast two-dimensional echocardiographic assessment of perfusion defects in ischemic myocardium. Sakamaki T; Tei C; Meerbaum S; Shimoura K; Kondo S; Fishbein MC; Y-Rit J; Shah PM; Corday E J Am Coll Cardiol; 1984 Jan; 3(1):34-8. PubMed ID: 6197433 [TBL] [Abstract][Full Text] [Related]
46. Oxygen supply and microcirculation of the beating dog heart after haemodilution with fluosol DA 20%. Harrison DK; Günther H; Vogel H; Ellermann R; Brunner M; Höper J; Kessler M Adv Exp Med Biol; 1985; 191():445-52. PubMed ID: 3832859 [No Abstract] [Full Text] [Related]
47. Antipyrine kinetics following partial blood exchange with Fluosol-DA in the rat. Shrewsbury RP; White SG; Pollack GM; Wargin WA J Pharm Pharmacol; 1986 Dec; 38(12):883-7. PubMed ID: 2880960 [TBL] [Abstract][Full Text] [Related]
48. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping. Novick RJ; Stefaniszyn HJ; Michel RP; Burdon FD; Salerno TA J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028 [TBL] [Abstract][Full Text] [Related]
49. Dissociation of ST segment elevation and regional wall motion with open-artery, intracoronary Fluosol. Schaer GL; Krucoff MW; Green C; Visner MS Am Heart J; 1989 Oct; 118(4):679-85. PubMed ID: 2529747 [TBL] [Abstract][Full Text] [Related]
50. Effect of a perfluorocarbon emulsion (Fluosol-DA) on reticuloendothelial system clearance function. Castro O; Nesbitt AE; Lyles D Am J Hematol; 1984 Jan; 16(1):15-21. PubMed ID: 6695906 [TBL] [Abstract][Full Text] [Related]
51. The effect of Fluosol-DA on oxygen availability in focal cerebral ischemia. Sutherland GR; Farrar JK; Peerless SJ Stroke; 1984; 15(5):829-35. PubMed ID: 6433517 [TBL] [Abstract][Full Text] [Related]
53. Effect of moderate haemodilution with Fluosol-DA or normal saline on low-dose phenytoin and (+/-)-5-(4-hydroxyphenyl)-5-phenylhydantoin kinetics. Shrewsbury RP; Lewis LM; Oliver SR J Pharm Pharmacol; 1987 May; 39(5):349-56. PubMed ID: 2886583 [TBL] [Abstract][Full Text] [Related]
54. Effects of fluorocarbons with and without oxygen supplementation on cardiac hemodynamics and energetics. Rude RE; Bush LR; Tilton GD Am J Cardiol; 1984 Oct; 54(7):880-3. PubMed ID: 6207721 [TBL] [Abstract][Full Text] [Related]
55. The importance of defining left ventricular area at risk in vivo during acute myocardial infarction: an experimental evaluation with myocardial contrast two-dimensional echocardiography. Kaul S; Glasheen W; Ruddy TD; Pandian NG; Weyman AE; Okada RD Circulation; 1987 Jun; 75(6):1249-60. PubMed ID: 3032476 [TBL] [Abstract][Full Text] [Related]
56. Relations between 2-dimensional echocardiographic wall thickening abnormalities, myocardial infarct size and coronary risk area in normal and hypertrophied myocardium in dogs. Pandian NG; Koyanagi S; Skorton DJ; Collins SM; Eastham CL; Kieso RA; Marcus ML; Kerber RE Am J Cardiol; 1983 Dec; 52(10):1318-25. PubMed ID: 6228135 [TBL] [Abstract][Full Text] [Related]
57. Differential enhancement of melphalan cytotoxicity in tumor and normal tissue by Fluosol-DA and oxygen breathing. Teicher BA; Holden SA; Rose CM Int J Cancer; 1985 Nov; 36(5):585-9. PubMed ID: 3932225 [TBL] [Abstract][Full Text] [Related]
58. Surgical use of fluosol-DA in Jehovah's Witness patients. Ohyanagi H; Nakaya S; Okumura S; Saitoh Y Artif Organs; 1984 Feb; 8(1):10-8. PubMed ID: 6703920 [TBL] [Abstract][Full Text] [Related]
59. The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo. Teicher BA; Herman TS; Holden SA; Cathcart KN Cancer Chemother Pharmacol; 1988; 21(4):286-91. PubMed ID: 3131033 [TBL] [Abstract][Full Text] [Related]
60. Effects of Fluosol-DA and oxygen breathing on adriamycin antitumor activity and cardiac toxicity in mice. Teicher BA; Holden SA; Crawford JM Cancer; 1988 Jun; 61(11):2196-201. PubMed ID: 3365649 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]